ESC 365 - Eligibility and preference of extended antithrombotic therapy for secondary prevention after an acute coronary syndrome

ESC Premium Access

Eligibility and preference of extended antithrombotic therapy for secondary prevention after an acute coronary syndrome

Session: Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet

Topic: Pharmacotherapy

Speaker: Doctor D. Candeias Faria (Faro, PT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Daniel Alexandre Candeias Faria

University Hospital Center of Algarve, Faro (Portugal)

2 presentations

1 follower

9 more presentations in this session

Ischemic and bleeding events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients: a propensity score-matched analysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)

Predictors of bleeding in elderly patients with myocardial infarction: data from the real world

Speaker: Doctor S. Alegria (Almada, PT)

Myocardial infarction with nonobstructive coronary arteries: does aspirin have a place in the treatment of this entity?

Speaker: Doctor J. Ferreira (Coimbra, PT)

Potential for drug-drug interaction between vonoprazan and prasugrel on antiplatelet effect assessed by VerifyNow P2Y12 assay in patients with coronary artery disease

Speaker: Doctor S. Koga (Tokyo, JP)

Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome

Speaker: Doctor F. Scudiero (Seriate, IT)

Access the full session

Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet

Speakers: Doctor D. Candeias Faria, Doctor A. Shimizu, Doctor S. Alegria, Doctor J. Ferreira, Doctor S. Koga...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources